Medical News

RSS

First Edition: November 19, 2013

Today's headlines include news that Obama administration officials were warned about the possibility of website difficulties months ago by an outside consulting firm.

19 Nov 2013

U-M researchers collaborate with MDCH to evaluate statewide influenza vaccination reminder campaign

A new University of Michigan study found that the state immunization registry - the public health database that tracks vaccinations- can be an effective tool to encourage influenza vaccinations during a pandemic.

19 Nov 2013

Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Women with depression in the perinatal period experience a high degree of conflict in deciding whether and how to treat their depression, but strongly prefer treatments other than antidepressant medications, reports a study in the November Journal of Psychiatric Practice®. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Nov 2013

Lowering body temperature improves survival, neurological outcome in cardiac arrest patients

Francis Kim, M.D., of Harborview Medical Center, Seattle, and colleagues evaluated whether early prehospital cooling (lowering body temperature) improved survival to hospital discharge and neurological outcome in cardiac arrest patients with or without ventricular fibrillation (VF).

19 Nov 2013

Scientists at Salk Institute develop novel platform to study kidney diseases

Diseases affecting the kidneys represent a major and unsolved health issue worldwide. The kidneys rarely recover function once they are damaged by disease, highlighting the urgent need for better knowledge of kidney development and physiology.

19 Nov 2013

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.

19 Nov 2013

KLOX receives CE mark approval in Europe for non-invasive acne vulgaris treatment

KLOX Technologies Inc. is pleased to announce that it has received CE mark approval in Europe for its topical photo-converter gel as a Class IIa Medical Device for the treatment of acne vulgaris, including all severities. The gel is part of KLOX's LumiCleanse System, a first-in-class innovative, non-invasive acne vulgaris treatment with a clinically-proven superior safety and efficacy profile. The LumiCleanseTM System was previously approved for the treatment of all severities of acne vulgaris in Canada in September of this year.

19 Nov 2013

$New trial assess effects on hip fracture, colorectal cancer incidence in postmenopausal women$

New trial assess effects on hip fracture, colorectal cancer incidence in postmenopausal women

New results are in from the Women's Health Initiative (WHI) Calcium plus Vitamin D Supplementation Trial. These findings assess the effects on hip fracture and colorectal cancer incidence among 30,000 postmenopausal women nearly five years after the seven-year period of calcium plus vitamin D supplementation ended.

19 Nov 2013

Health insurers face an uncertain future

WellPoint Inc., the parent of Anthem Blue Cross and Blue Shield in Missouri, took a huge gamble when it dove headfirst into many of the new health insurance marketplaces around the country. Aetna Inc. hedged its bets by entering a patchwork of federal- and state-run health exchanges, but skipped California and New York, two of the most populous markets. UnitedHealth Group Inc., the nation's largest health insurer, decided to participate in only a dozen or fewer exchanges in 2013.

19 Nov 2013

GM-CSF therapy does not improve treadmill walking time in patients with peripheral artery disease

Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).

19 Nov 2013

AGA, Covidien partner to improve lives of people struggling with digestive diseases

The American Gastroenterological Association Institute announced today that Covidien, a leading global provider of health-care products, recently agreed to expand its corporate grant to the AGA Institute.

19 Nov 2013

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Patients with acute coronary syndrome who were treated with the experimental drug varespladib were more likely to experience additional cardiovascular events - including sudden death, heart attack and stroke - than those treated with placebo, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).

19 Nov 2013

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

A blood cell growth factor can boost the effects of exercise in improving mobility for patients with peripheral artery disease, a clinical study has shown.

19 Nov 2013

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.

19 Nov 2013

WNBA, Africare, NBA and ExxonMobil launch "Power Forward" to develop health, leadership in Nigeria

The National Basketball Association, Women's National Basketball Association, Africare and ExxonMobil today announced the launch of "Power Forward," a youth engagement initiative that will use basketball to develop health, leadership and life skills in Nigeria.

19 Nov 2013

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Pioneering research by the Optoelectronics Research Centre that could transform the care of cancer patients or people with infections in their own homes has received a significant grant from the Engineering and Physical Sciences Research Council.

19 Nov 2013

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

The Boston Scientific Corporation Vercise Deep Brain Stimulation System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

19 Nov 2013

Orthopaedic specialist offers tips to prevent painful holiday season

While the holiday season is a selfless time of year, individuals are encouraged to keep in-tune with their bodies as the festive shopping, baking, and cleaning often triggers bodily aches and pains.

19 Nov 2013

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).

19 Nov 2013

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

BBI Solutions, a world leader in immunoassay development and contract manufacturing, recently launched its unique range of Recombinant Fab Monoclonal Antibodies at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo, on July 28-August 31, 2013, in Houston, Texas.

19 Nov 2013

Medical News

First Edition: November 19, 2013

U-M researchers collaborate with MDCH to evaluate statewide influenza vaccination reminder campaign

Study on women's preferences, decision-making patterns regarding treatment for depression during, after pregnancy

Lowering body temperature improves survival, neurological outcome in cardiac arrest patients

Scientists at Salk Institute develop novel platform to study kidney diseases

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

KLOX receives CE mark approval in Europe for non-invasive acne vulgaris treatment

New trial assess effects on hip fracture, colorectal cancer incidence in postmenopausal women

Health insurers face an uncertain future

GM-CSF therapy does not improve treadmill walking time in patients with peripheral artery disease

AGA, Covidien partner to improve lives of people struggling with digestive diseases

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

WNBA, Africare, NBA and ExxonMobil launch "Power Forward" to develop health, leadership in Nigeria

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

Orthopaedic specialist offers tips to prevent painful holiday season

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News